Pembrolizumab will be made available for some adults in Scotland with bowel cancer that’s spread to other parts of the body.
There has been a lot of excitement about the Galleri test, and it’s obvious to see why. Here are three things you need to about this multi-cancer blood test.
As chair of our philanthropic giving circle the Catalyst Club, businessman Simon Collins is helping to unlock transformational funding to support our life-saving research. Meet Simon and learn more about the Catalyst Club, which turns 10 this year.
Find out how the chemistry inside plants can lead to life-changing drugs and how a cannabis-derived drug is part of a new trial to help people with a type of aggressive brain cancer.
During the 2019 Six Nations,122.4 billion Guinness-related branded impressions were delivered to the UK population who watched the coverage.
LGBTQ+ communities experience inequalities throughout their cancer journey, including in screening and diagnosis, clinical care, communication and overall experience. Find out about the barriers the community faces and the commitments required to improve cancer care for LGBTQ+ people.
The National Institute of Health and Care Excellence (NICE) has approved the use of pemigatinib in adults with a rare type of bile duct cancer that has continued to advance or spread after initial chemotherapy.
A Cardiff University-led UK-wide survey has found that more than 1 in 5 people are less likely to take part in cancer screening than before the pandemic.